Aramark US earnings missed by $0.04, revenue fell short of estimates

Aramark US (ARMK) reported Q4 EPS of $0.71, missing estimates by $0.04, with revenue at $5.29B, below the $5.3B consensus. The stock is down 9.77% over 3 months but up 49.67% over 12 months. InvestingPro rates its financial health as 'good performance.'

Original reporting
Published Nov 16, 2026, 11:49 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 16, 2026, 12:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ARMK
Bearish
high confidence
Mentioned
$ARMK
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$ARMKBearishLow
01

Why it matters

Earnings miss may trigger short-term sell pressure, but fundamentals remain solid.

02

Market read

The earnings miss is a modest negative catalyst for ARMK and its sector.

03

What to watch

Recent cost-control initiatives and upcoming contract renewals may mitigate the short-term earnings weakness.

Relevance 7/10Novelty 6/10Timing: post-market release

Background

Aramark US is a leading provider of food services and facilities management, listed on NYSE under ARMK.

Company-level read

Ticker impact

$ARMKBearishHigh confidence
Context

Aramark US reported Q4 EPS of $0.71, missing estimates by $0.04 and revenue of $5.29B, slightly below the $5.3B consensus.

Expected impact

likely downward pressure as investors price in the earnings shortfall

Evidence & confidence

The miss on both EPS and revenue, combined with a recent decline in the stock, points to short-term weakness.

Market effects

Food services and contract catering sector may see modest pressure as a mid-cap peer missed estimates.

U.S. equities may experience slight bearish bias in the consumer discretionary segment.

Limited; impact confined to U.S. markets and sector peers.

Counterpoint

The miss is marginal; the stock's long-term growth trajectory could still be intact, offering a potential buying opportunity on dip.

Key entities

  • Aramark US

    Food services and facilities management provider.

Related articles

$ARMKMed

Aramark Q4 2026 Earnings Call Summary

Aramark reported record annualized gross new client wins of $1.9 billion, a 97% client retention rate, and launched Aramark Nexus. The company reduced its leverage ratio to 2.7x, enabling a $1 billion share repurchase program and a 17% dividend increase. For fiscal 2027, Aramark projects $500 million in revenue from Nexus, 9-10% organic revenue growth, and 15-19% adjusted operating income growth. Management highlighted supply chain efficiencies and mitigating inflation impacts.

$ARMKMed

Aramark (ARMK) Q4 2026 Earnings Call Transcript

Aramark (ARMK) reported Q4 2026 revenue of $20.1B, up 10% YoY, with U.S. and international organic growth of 8% and 12%, respectively. Adjusted EPS grew 21% on a constant currency basis. The company announced a $1B share repurchase program and a 17% dividend increase. Key segments like Collegiate Hospitality and Healthcare Plus drove growth. Aramark Nexus contributed 1% to organic revenue growth, scaling premium hospitality services.

$ARMKHigh

Why is Aramark stock sliding today?

Aramark (ARMK) shares fell 4.7% pre-market after reporting Q4 2026 results that missed estimates, with adjusted EPS at $0.71 vs. $0.75 and revenue at $5.29B vs. $5.30B. The company's fiscal 2027 guidance also fell short of expectations. Despite a 25% YoY EPS increase and 4.8% revenue growth, the stock dropped due to broader market pressures and the earnings miss.

$ARMKMedAI 8/10

Aramark Q4 Results Climb, Sees Growth In FY27; Lifts Dividend, Plans $1 Bln Buyback; But Stock Down

Aramark (ARMK) reported Q4 profit and revenue growth, with net earnings rising to $137.94M ($0.51 per share) from $87.14M ($0.33 per share) a year ago. The company projects FY27 organic EPS growth of 20-25%, operating income growth of 15-19%, and revenue growth of 9-10%. It also announced a $1B share buyback program and a 17% dividend increase. Shares were down 5.45% in pre-market trading.